We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
STAAR Surgical Company | NASDAQ:STAA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.07 | 0.15% | 46.96 | 46.58 | 47.40 | 48.02 | 46.43 | 47.14 | 335,626 | 01:00:00 |
3 (a) Title of the Class of Securities To Be Sold |
(b)
Name
and Address of Each Broker Through Whom the
|
SEC USE ONLY |
(c)
Number
of Shares
|
(d) Value (See instr. 3(d)) |
(e)
Number
of Shares
|
(f)
Approximate
(See instr. 3(f))
|
(g)
Name
of Each
(See instr. 3(g)) |
Broker-Dealer
File Number |
|||||||
Common Stock, par value $0.01 per share |
BTIG, LLC 600 Montgomery Street, 6th Floor San Francisco, California 94111 |
60,000 | $5,365,200 | 46,109,765 | January 12, 2021 | NASDAQ |
TABLE I –– SECURITIES TO BE SOLD
Furnish
the following information with respect to the acquisition of the securities to be sold
and with respect to the payment of all or any part of the purchase price or
other consideration therefor:
Title of
the Class |
Date you
Acquired |
Nature of Acquisition Transaction |
Name of Person from Whom Acquired
(If gift, also give date donor acquired) |
Amount of
Securities Acquired |
Date of
Payment |
Nature of Payment | |
Common Stock, par value $0.01 per share | May 3, 2019 | Purchases | The shares were purchased in an open market transaction. | 100,000 | May 3, 2019 | Cash |
INSTRUCTIONS: If the securities were purchased and full payment therefor was not made in cash at
the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.
TABLE II –– SECURITIES SOLD DURING THE PAST 3 MONTHS
Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.
Name and Address of Seller | Title of Securities Sold | Date of Sale |
Amount of
Securities Sold |
Gross Proceeds |
REMARKS:
INSTRUCTIONS: See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice. |
ATTENTION: The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-I under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date. |
January 12, 2021 | |||||
DATE OF NOTICE | (SIGNATURE) | ||||
DATE OF PLAN ADOPTION OR GIVING OF INSTRUCTION,
IF RELYING ON RULE 1085-1 |
The notice shall be signed by the person for whose account the securities are to be sold. At least one copy
of the notice shall be manually signed. Any copies not manually signed shall bear typed or printed signatures. |
ATTENTION: Intentional misstatements or omission of facts constitute. Federal Criminal Violations (See 18 U.S.C. 1001) |
1 Year STAAR Surgical Chart |
1 Month STAAR Surgical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions